| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HCA | Common Stock, par value $0.01 per share | Purchase | $866K | +4.13K | +1.06% | $209.73 | 394K | May 2, 2022 | Direct | F1 |
| transaction | HCA | Common Stock, par value $0.01 per share | Purchase | $7.92M | +37.6K | +9.55% | $210.60 | 432K | May 2, 2022 | Direct | F2 |
| transaction | HCA | Common Stock, par value $0.01 per share | Purchase | $3.45M | +16.3K | +3.78% | $211.22 | 448K | May 2, 2022 | Direct | F3 |
| transaction | HCA | Common Stock, par value $0.01 per share | Purchase | $767K | +3.61K | +0.81% | $212.60 | 452K | May 2, 2022 | Direct | F4 |
| transaction | HCA | Common Stock, par value $0.01 per share | Purchase | $1.64M | +7.68K | +1.7% | $213.47 | 459K | May 2, 2022 | Direct | F5 |
| transaction | HCA | Common Stock, par value $0.01 per share | Purchase | $2.61M | +12.2K | +2.65% | $214.48 | 471K | May 2, 2022 | Direct | F6 |
| transaction | HCA | Common Stock, par value $0.01 per share | Purchase | $1.63M | +7.58K | +1.61% | $215.29 | 479K | May 2, 2022 | Direct | F7 |
| holding | HCA | Common Stock, par value $0.01 per share | 308K | May 2, 2022 | Held indirectly through Hercules Holding II | F8, F9 | |||||
| holding | HCA | Common Stock, par value $0.01 per share | 72.6K | May 2, 2022 | Held indirectly through Hercules Holding II by Thomas F. Frist GST Tax Exempt Trust | F8, F10 | |||||
| holding | HCA | Common Stock, par value $0.01 per share | 232K | May 2, 2022 | Held indirectly through Hercules Holding II by Patricia Champion Frist 2020 GRAT | F8, F10 | |||||
| holding | HCA | Common Stock, par value $0.01 per share | 36.6M | May 2, 2022 | Held indirectly through Hercules Holding II by Frisco, Inc. | F8, F11 |
| Id | Content |
|---|---|
| F1 | The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $209.40 to $209.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F2 | The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $210.00 to $210.99, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F3 | The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $211.00 to $211.89, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F4 | The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $212.06 to $212.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F5 | The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $213.02 to $213.98, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F6 | The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $214.00 to $214.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F7 | The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $215.05 to $215.71, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F8 | Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
| F9 | The Reporting Person directly owns 307,936.079368 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of his ownership in Hercules. |
| F10 | The Reporting Person is trustee of (i) the Thomas F. Frist GST Tax Exempt Trust and (ii) the Patricia Champion Frist 2020 Grantor Retained Annuity Trust and may be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. |
| F11 | The Reporting Person may be deemed to share voting and dispositive power with respect to 36,629,163.8593 shares of HCA Healthcare, Inc. beneficially owned by Frisco, Inc., by virtue of his position as a director of Frisco, Inc. Frisco, Inc. has beneficial ownership of 36,629,163.8593 units of Hercules, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. |